Omeros Investigational Site

Flushing, New York 11355

We've found

2 trials

at this facility

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Status: Enrolling, Phase II
Updated: 1/11/2018

from

Flushing, NY

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Flushing, NY

Use our guide to learn which trials are right for you!